Kozak & Associates, Inc. - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 30 filers reported holding VIVOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kozak & Associates, Inc. ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$335
-44.4%
1,2050.0%0.00%
Q2 2023$602
+46.5%
1,2050.0%0.00%
Q1 2023$4111,2050.0%0.00%
Q4 2022$0
-100.0%
1,2050.0%0.00%
-100.0%
Q3 2022$1,000
-50.0%
1,2050.0%0.00%0.0%
Q2 2022$2,000
-50.0%
1,2050.0%0.00%
-66.7%
Q1 2022$4,0000.0%1,2050.0%0.00%0.0%
Q4 2021$4,000
-20.0%
1,2050.0%0.00%0.0%
Q3 2021$5,0001,2050.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 162,500$804,0000.46%
BARD ASSOCIATES INC 215,500$1,067,0000.35%
Millrace Asset Group, Inc. 93,993$465,0000.24%
Archon Capital Management LLC 215,000$1,064,0000.12%
Penn Capital Management Company, LLC 223,403$1,106,0000.11%
GRIFFIN ASSET MANAGEMENT, INC. 49,500$245,0000.03%
K2 PRINCIPAL FUND, L.P. 64,746$320,0000.03%
Walleye Capital LLC 150,000$743,0000.02%
WMS Partners, LLC 16,667$153,0000.02%
Avalon Investment & Advisory 189,739$939,0000.02%
View complete list of VIVOS THERAPEUTICS INC shareholders